Yearly 160 BW of pharmaceutical business losses under FTA.

Published: 2007-05-02 07:00:00

Updated: 2007-05-02 07:00:00

It is estimated for the local pharmaceutical industry to face about 90.4 to 168.8 billion won of annual pharmaceutical sales losses for 10 years under the KORUS FTA according to "Analysis of KORUS FTA economic effects" released on April 30 by 11 national research institutes including the governme...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK